Spectranetics, Biolase receive FDA approval

17 Jun 2002

The Food and Drug Administration's Circulator System DevicesPanel Advisory Committee has given its unanimous recommendationfor Spectranetics Corporation to use its Laser Sheath to removepacemaker and implantable cardioverter defibrillator leads. Therecommendation included certain labeling changes and will bereviewed by the FDA before final approval. The FDA also allowedBiolase Technology to market its DermaLase Er,Cr:YSGG lasersystem for a range of dermatological and general surgicalapplications.
(courtesy Laser Focus World)